The Life Sciences Americas Awards has shortlisted WilmerHale and six of its lawyers across 10 categories in its 2026 rankings, recognizing the firm’s leading transactional, regulatory and litigation work in the life sciences industry.
The firm is a finalist for:
- M&A Firm of the Year
- Venture Capital Firm of the Year
- Hatch-Waxman Litigation Firm of the Year – Branded
- Securities Litigation Firm of the Year
Individual finalists include:
- Cynthia Mazareas — Corporate Attorney of the Year
- Hal Leibowitz — M&A Attorney of the Year
- Stuart Falber — Venture Capital Attorney of the Year
- Emily Whelan — General Patent Litigator of the Year – New England
- David Cavanaugh — Post-Grant Proceedings Attorney of the Year
- George O'Brien — Regulatory Attorney of the Year: FDA Pharmaceutical
Presented by Legal Benchmarking Group, the Life Sciences Americas Awards honor leading law firms and practitioners advancing the life sciences industry. Winners will be announced on September 10 at a gala ceremony in New York City.